Search Results 1831-1840 of 21306 for anti-TNF drugs

1. A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Chronic daily treatment with a nonsteroidal anti-inflammatory drug (NSAID).

2. Neomycin, Polymyxin B, And Dexamethasone (Ophthalmic Route) Proper Use - Mayo Clinic

   To help clear up your infection completely, keep using this medicine for the full treatment time even if you feel better after the first few doses. The ...

3. Corticosteroid (Rectal Route) Description and Brand Names - Mayo Clinic

   They also may be used along with systemic (oral or injection) corticosteroids or other medicines to treat severe disease or mild to moderate disease that has ...

4. NSAIDS Archives - Mayo Clinic News Network

   DEAR MAYO CLINIC: Is it true that taking prescription-strength nonsteroidal anti-inflammatory drugs, or NSAIDs, can increase my risk of heart disease? How much ...

5. Hydralazine And Hydrochlorothiazide (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

6. Temozolomide (Oral Route) Proper Use - Mayo Clinic

   The dose is usually 75 milligrams (mg) per square meter (m[2]) of body size once day for 42 to 49 days together with radiation treatment. Followed by a ...

7. Probenecid (Oral Route) Proper Use - Mayo Clinic

   Proper Use. Drug information provided by: Merative, Micromedex®. If probenecid upsets your stomach, it may be taken with food. If this does not work, ...

8. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   ... drug;; Prior therapy with any agents targeting immune coinhibitory receptors (e.g., anti-PD-1,anti-PD-L1, anti-PD-L2, anti-CTLA-4), or costimulatory receptor ...

9. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors - Mayo Clinic

   ... anti-hypertensive medication to Grade ≤ 1 are eligible); Prior or concurrent malignancy with known RAS mutation; Previous treatment with vemurafenib or any ...

10. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    ... anti-drug antibody (ADA) to a CD25 antibody. Allogenic or autologous transplant within 60 days prior to start of study drug. Active graft-versus-host ...